Introduction
Over the past few years controversial evidence has suggested that human papillomavirus is associated with the development of cervical cancer. Human papillomavirus 16 and 18 sequences have been found in a high proportion of cervical carcinomas.' Cases of genital warts seen at clinics for sexually transmitted diseases in the United Kingdom have increased from 20334 in 1973 to 49884 in 1984.2 Exophytic condylomas have been reported in up to 6% of women with vulval warts,'-' and genital warts are common in women who attend gynaecology clinics and clinics for sexually transmitted diseases. Numerous reports have attempted to link the incidence of human papillomavirus infection with abnormal results of cervical screening but we do not know of any reports of screening for cervical cancer and human papillomavirus in a general medical practice. 6 Recent reports show that the overall death rate from cancer of the cervix has declined but the death rate in younger age groups has increased. Between 1968 and 1984 deaths from cervical cancer fell from 12-53 to 9-10 per 100 000, but in women aged under 30 they increased more than fourfold from 0-22 to 0-91 per 100000. Further rises are predicted in this younger group, which will cause a decrease in the overall downward trend in mortality in the next 10 years unless effective intervention by cervical screening is undertaken.7" Several reports from different countries have shown that screening of the population has been followed by a decrease in the incidence of invasive disease.9 "' In 1964 a large scale cervical cytological screening service was started in Britain; since then mortality from cervical cancer has declined at 1% a year." , 2 We report the findings of cervical screening in our general practice and give details of four women under 30 with grade III cervical intraepithelial neoplasia, three of whom had human papillomavirus infection.
Patients and methods
Our general practice is an inner city suburb of north Birmingham and has a list size of 9900 patients, of whom 3301 are women aged 14 she had suffered a protracted attack of cervical, vulvovaginal, perineal, and anal warts, which had been treated initially with podophyllin and later, after she was referred to a gynaecology clinic, with laser treatment. The third patient with cervical intraepithelial neoplasia grade III was 23 when her smear showed viral effects with cervical intraepithelial neoplasia grade II; seven months later this had progressed to grade III. Colposcopy showed grade II disease and human papillomavirus infection. She was given laser treatment. The fourth patient, a 29 year old mother of two, had had a cervical smear five years previously. A routine smear taken when she attended for family planning advice showed cervical intraepithelial neoplasia grade II, and three months later grade III disease was evident. Colposcopy found high grade disease and early invasion. After laser excision histological examination confirmed grade III disease with glandular atypia and human papillomavirus infection.
Discussion
For many years the NHS has been complacent about cervical screening in general practice: the onus has been on women to present themselves at clinics and doctors' surgeries for this service, and health authorities have provided only limited facilities in cytology laboratories for smears to be checked. Most of the 91 patients (4-8%) found to have cervical intraepithelial neoplasia in this study would have been missed if they had not been actively encouraged to present for screening. In 87 of these women the neoplasia was found at an early stage, when treatment offers excellent results.
Condyloma acuminata of the cervix (exophytic condyloma) has been associated with characteristic findings of koilocytosis, dyskeratosis, and nuclear atypia on cytological examination.'5 Human papillomavirus types 16 and 18 sequences have been found in a high proportion of cervical carcinomas and cases of cervical intraepithelial neoplasia; the human papillomavirus 16 Mortality from cervical cancer has a strong social class gradient, the highest rate being found in social classes III, IV, and V.7 Patients in our practice are generally social classes III-V.'
Pressure is growing for family practitioner committees to attempt a coordinated screening policy with cytology laboratories. The call and recall systems that are being introduced may produce more accurate figures for cervical disease. 16 Nevertheless, the present complicated and bureaucratic system of remunerating general practitioners fails to encourage them to take cervical smears.
Though it is necessary to screen middle aged women, those cancers are currently not being identified until they are at an advanced stage, it is important not to become complacent about the younger age group. We strongly support the suggestion of Campion et al that all women whose cervical smear shows dyskaryotic cells should be referred for colposcopy, particularly as mortality in young women has increased appreciably.'7 Our study shows that an age barrier cannot be placed on screening: 65 of the 101 women with cervical intraepithelial neoplasia (3 4% of initial smears) were less than 35 years old. Furthermore the incidence of genital warts is increasing in young people at an alarming rate. Though it is not possible to predict the potential importance and magnitude of this disease in the long term in this young group, the present BMJ VOLUME 297 17 SEPTEMBER 1988 system does not allow for any monitoring. Screening should start much earlier if we are to prevent the untreatable cervical cancers in women over 40; extra pressure must be put on women at high risk so that they accept screening and attend when called. Many of these women are embarrassed about being examined; a large number adopt an ostrich approach and deny themselves routine tests through fear of an unfavourable diagnosis. Recall should be at least triennial if any difference in the mortality and morbidity from cancer of the cervix is to be achieved. 
